NCT02813135 2026-01-16ESMARTGustave Roussy, Cancer Campus, Grand ParisPhase 1/2 Recruiting472 enrolled
NCT03326310 2025-12-29Selumetinib and Azacitidine in High Risk Chronic Blood CancersUniversity of ChicagoPhase 1 Recruiting18 enrolled